Published on 2/3/2004 in the Prospect News Convertibles Daily.
New Issue: Goldman Sachs prices $10 million 4.875% notes exchangeable for MedImmune
New York, Feb. 3 - The Goldman Sachs Group Inc. priced $10 million of 4.875% one-year notes mandatorily exchangeable for the common stock of MedImmune Inc., according to a filing with the Securities and Exchange Commission.
Terms of the deal are as follows:
| Issuer: | The Goldman Sachs Group Inc.
|
| Issue: | Mandatory exchangeable medium-term notes
|
| Underlying stock: | MedImmune Inc.
|
| Amount: | $10 million
|
| Maturity: | Feb. 4, 2005
|
| Coupon: | 4.875%, payable quarterly
|
| Price: | Par of $21.0541
|
| Exchange ratio: | 1, capped at $27.3703 or 30% above initial price of $21.0541, in cash or stock at Goldman's option, at maturity
|
| Pricing date: | Jan. 27
|
| Settlement date: | Feb. 3
|
| Underwriter: | Goldman, Sachs & Co.
|
| Distribution: | Off shelf
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
